Alejandro Campos-Murguia
Overview
Explore the profile of Alejandro Campos-Murguia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
130
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Snijders R, Janik M, Mund M, Uhlenbusch N, Raszeja-Wyszomirska J, Gerussi A, et al.
Hepatology
. 2025 Feb;
PMID: 39970194
Background: Impaired health-related quality of life (HRQoL) contributes to the overall disease burden in autoimmune hepatitis (AIH). This study aimed to evaluate HRQoL in people with AIH and to identify...
2.
Campos-Murguia A, Hupa-Breier K, Hartleben B, Wedemeyer H, Taubert R, Engel B
Transplant Direct
. 2025 Jan;
10(3):e1592.
PMID: 39877649
Background: The noninvasive detection of subclinical graft injury including subclinical T cell-mediated rejection (subTCMR) is one of the unresolved challenges after liver transplantation. Recently, serum C-X-C motif chemokine ligand 8...
3.
Hupa-Breier K, Schenk H, Campos-Murguia A, Wellhoner F, Heidrich B, Dywicki J, et al.
Mol Metab
. 2025 Jan;
93:102104.
PMID: 39855563
Objective: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common cause of chronic liver disease, especially in patients with severe obesity. However, current mouse models for MASLD do not...
4.
Campos-Murguia A, Guetzlaff L, Bosselmann E, Engel B, Hartleben B, Wedemeyer H, et al.
Clin Transplant
. 2024 Nov;
38(11):e70039.
PMID: 39575514
Background And Aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a leading indication for liver transplantation (LT), but also occurs after LT. The prevalence of de novo MASLD (dnMASLD) after...
5.
Schregel I, Papp M, Sipeki N, Kovats P, Taubert R, Engel B, et al.
Liver Int
. 2024 Jul;
44(10):2687-2699.
PMID: 39037185
Background And Aims: The European Reference Network on Hepatological Diseases (ERN RARE-LIVER) launched the prospective, multicentre, quality-controlled R-LIVER registry on rare liver diseases. The aim of this study was to...
6.
Campos-Murguia A, Bosselmann E, Hartleben B, Wedemeyer H, Engel B, Taubert R, et al.
Front Transplant
. 2024 Jul;
2:1124551.
PMID: 38993902
Subclinical graft injuries in orthotopic liver transplantation may threaten long-term graft survival and could be the result of chronic under-immunosuppression. It is not known whether steroid withdrawal increases the risk...
7.
Bosselmann E, Dranicki F, Campos-Murguia A, Hartleben B, Wedemeyer H, Jaeckel E, et al.
Front Transplant
. 2024 Jul;
2:1168163.
PMID: 38993848
Introduction: The combination of everolimus (EVR) and low-dose tacrolimus (lowTAC) prevents T cell-mediated rejection of liver grafts as sufficiently as high-dose tacrolimus (highTAC) and mycophenolate, but is associated with a...
8.
Taubert R, Engel B, Campos-Murguia A
Front Med (Lausanne)
. 2023 Oct;
10:1275838.
PMID: 37809342
No abstract available.
9.
Ruiz-Margain A, Pohlmann A, Lanzerath S, Langheinrich M, Campos-Murguia A, Roman-Calleja B, et al.
JHEP Rep
. 2023 Aug;
5(8):100761.
PMID: 37554924
Background & Aims: Acute-on-chronic liver failure (ACLF) has been linked to different pathophysiological mechanisms, including systemic inflammation and mitochondrial dysfunction. Sarcopenia has also been proposed as a potential mechanism; myostatin...
10.
Engel B, Gorzer I, Campos-Murguia A, Hartleben B, Puchhammer-Stockl E, Jaeckel E, et al.
Front Immunol
. 2023 Aug;
14:1215868.
PMID: 37533865
Introduction: Torque teno virus (TTV) replication is controlled by immune status, mirroring a degree of immunosuppression after solid organ transplantation. TTV viraemia (TTVv) was associated with acute cellular rejection and...